Status:
COMPLETED
Medical Treatment of Peyronie's Disease With Collagenase Clostridium Histolyticum
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Peyronie Disease
Eligibility:
All Genders
18+ years
Brief Summary
Peyronie's disease is the appearance of a fibrosis plaque on the albuginea of the corpora cavernosa, which produces mechanical traction at the time of erection, inducing a deformation/curvature of the...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age ≥ 18 years old
- Peyronie's disease stable for more than 3 months after 12 to 18 months of evolution
- Angle of penis deformation ≥ 30°
- Exclusion criteria:
- Surgery for Peyronie's disease before
- Anticoagulation
Exclusion
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT04370652
Start Date
January 1 2015
End Date
December 30 2019
Last Update
May 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295